Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation

BACKGROUND: Previous cost-effectiveness studies of cholinesterase inhibitors have modeled Alzheimer's disease (AD) progression and treatment effects through single or global severity measures, or progression to "Full Time Care". This analysis evaluates the cost-effectiveness of donepe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartz, Susanne, Getsios, Denis, Tao, Sunning, Blume, Steve, Maclaine, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296601/
https://www.ncbi.nlm.nih.gov/pubmed/22316501
http://dx.doi.org/10.1186/1471-2377-12-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296601/
https://www.ncbi.nlm.nih.gov/pubmed/22316501
http://dx.doi.org/10.1186/1471-2377-12-2

Ejemplares similares